cemiplimab
R2810-ONC-1866
Phase 3 small_molecule active
Quick answer
cemiplimab for Non-small Cell Lung Cancer is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Non-small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active